Karolina Agnieszka Wartolowska (Karolina Wartolowska, Karolina A Feakins, Karolina A Wartolowska)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Topics

Pulmonary Arterial Hypertension

Top Venues

Circulation research

European heart journal

This page only lists publications with an associated author ORCID identifier.

Publications

Alastair John Stewart Webb, Jacqueline Susan Birks, Karolina Agnieszka Wartolowska, Amy Lawson, Jesse Dawson, Alexander M K Rothman, David John Werring, Osian Llwyd, Catriona R Stewart, James Thomas
Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial. Circulation research 135 (2) (2024)
Alastair John Stewart Webb, Jacqueline Susan Birks, Karolina Agnieszka Wartolowska, Amy Lawson, Jesse Dawson, Alexander M K Rothman, David John Werring, Osian Llwyd, Catriona R Stewart, James Thomas
Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial. Circulation research 135 (2) (2024)
Alastair John Stewart Webb, Jacqueline Susan Birks, Karolina Agnieszka Wartolowska, Amy Lawson, Jesse Dawson, Alexander M K Rothman, David John Werring, Osian Llwyd, Catriona R Stewart, James Thomas
Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial. Circulation research (2024)
Alastair John Stewart Webb, Jacqueline Susan Birks, Karolina Agnieszka Wartolowska, Amy Lawson, Jesse Dawson, Alexander M K Rothman, David John Werring, Osian Llwyd, Catriona R Stewart, James Thomas
Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial. Circulation research 135 (2) (2024)
Alastair John Stewart Webb, Jacqueline Susan Birks, Karolina Agnieszka Wartolowska, Amy Lawson, Jesse Dawson, Alexander M K Rothman, David John Werring, Osian Llwyd, Catriona R Stewart, James Thomas
Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial. Circulation research (2024)
Alastair John Stewart Webb, Jacqueline Susan Birks, Karolina Agnieszka Wartolowska, Amy Lawson, Jesse Dawson, Alexander M K Rothman, David John Werring, Osian Llwyd, Catriona R Stewart, James Thomas
Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial. Circulation research 135 (2) (2024)
Karolina Agnieszka Wartolowska, David J Hohenschurz-Schmidt, Lene Vase, Jeffrey K Aronson
The importance of using placebo controls in non-pharmacological randomised trials. Pain (2022)
Owen J Sweeney, Sai Arathi Parepalli, Neginsadat Mirtorabi, Kimberley Kim Foon Loo Yong Kee, Benjamin G Feakins, Jeffrey K Aronson, Karolina Agnieszka Wartolowska
Placebo's invisible brother: a restricted scoping review of the biomedical literature on the nocebo effect. Pain 163 (11) (2022)
Michael H Bernstein, Maayan N Rosenfield, Charlotte Blease, Molly Magill, Richard M Terek, Julian Savulescu, Francesca L Beaudoin, Josiah D Rich, Karolina Agnieszka Wartolowska
How do US orthopaedic surgeons view placebo-controlled surgical trials? A pilot online survey study. Journal of medical ethics (2022)
Stefan Kluzek, Benjamin Dean, Karolina Agnieszka Wartolowska
Patient-reported outcome measures (PROMs) as proof of treatment efficacy. BMJ evidence-based medicine (2021)
Alastair John Stewart Webb, Amy Lawson, Karolina Agnieszka Wartolowska, Sara Mazzucco, Peter M Rothwell, null null
Aortic Stiffness, Pulse Pressure, and Cerebral Pulsatility Progress Despite Best Medical Management: The OXVASC Cohort. Stroke (2021)
Karolina Agnieszka Wartolowska, Alastair John Stewart Webb
Big cohort studies offer insights into preventable risk factors. European heart journal 42 (41) (2021)
Karolina Agnieszka Wartolowska
The nocebo effect as a source of bias in the assessment of treatment effects. F1000Research 8 (2019)
Karolina Agnieszka Wartolowska, David Beard, Andrew Carr
Blinding in trials of interventional procedures is possible and worthwhile. F1000Research (2017)
Karolina Agnieszka Wartolowska, David Beard, Andrew Carr
Blinding in trials of interventional procedures is possible and worthwhile. F1000Research 6 (2017)